Company Quick10K Filing
Avangrid
10-Q 2021-03-31 Filed 2021-05-04
10-K 2020-12-31 Filed 2021-03-01
10-Q 2020-09-30 Filed 2020-10-30
10-Q 2020-06-30 Filed 2020-07-31
10-Q 2020-03-31 Filed 2020-05-05
10-K 2019-12-31 Filed 2020-03-02
10-Q 2019-09-30 Filed 2019-10-31
10-Q 2019-06-30 Filed 2019-08-01
10-Q 2019-03-31 Filed 2019-05-02
10-K 2018-12-31 Filed 2019-03-01
10-Q 2018-09-30 Filed 2018-11-02
10-Q 2018-06-30 Filed 2018-08-02
10-Q 2018-03-31 Filed 2018-05-03
10-K 2017-12-31 Filed 2018-03-26
10-Q 2017-09-30 Filed 2017-11-02
10-Q 2017-06-30 Filed 2017-08-01
10-Q 2017-03-31 Filed 2017-05-05
10-K 2016-12-31 Filed 2017-03-10
10-Q 2016-09-30 Filed 2016-11-04
10-Q 2016-06-30 Filed 2016-08-04
10-Q 2016-03-31 Filed 2016-05-12
10-K 2015-12-31 Filed 2016-04-01
10-Q 2015-09-30 Filed 2015-12-16
8-K 2021-02-23
8-K 2021-02-15
8-K 2021-02-02
8-K 2020-12-29
8-K 2020-12-14
8-K 2020-10-20
8-K 2020-10-20
8-K 2020-07-21
8-K 2020-06-25
8-K 2020-06-22
8-K 2020-06-22
8-K 2020-06-11
8-K 2020-04-28
8-K 2020-04-07
8-K 2020-03-18
8-K 2020-03-11
8-K 2020-03-01
8-K 2020-02-25
8-K 2020-02-19
8-K 2019-12-31
8-K 2019-12-12
8-K 2019-12-03
8-K 2019-10-29
8-K 2019-07-23
8-K 2019-06-30
8-K 2019-06-27
8-K 2019-06-05
8-K 2019-05-14
8-K 2019-04-24
8-K 2019-02-19
8-K 2019-02-13
8-K 2018-12-18
8-K 2018-12-03
8-K 2018-10-23
8-K 2018-10-18
8-K 2018-10-09
8-K 2018-09-27
8-K 2018-07-24
8-K 2018-07-19
8-K 2018-06-29
8-K 2018-06-18
8-K 2018-06-13
8-K 2018-06-07
8-K 2018-04-25
8-K 2018-04-23
8-K 2018-03-16
8-K 2018-03-09
8-K 2018-02-20
8-K 2018-02-16
8-K 2018-02-16
8-K 2018-02-15
8-K 2018-01-31

Avangrid Financials

AGR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1,05042740339618291303627414057404338172108
Accounts Receivable7239749648949561,1191,1179849431,0401,1139861,0601,1421,2641,009966
Inventory
PP&E17,02920,69820,83021,12421,54821,79722,29022,68222,66922,75722,91723,12523,45923,55524,37324,750
Assets24,39730,74330,53930,41130,60931,30931,39631,48531,92131,67131,48331,37631,75532,16732,60833,14133,547
Accounts Payable5768303
Long-Term Debt2,9674,9854,6854,6754,5865,2044,8325,0805,0345,7995,3745,6235,6195,9525,8126,6566,950
Liabilities11,75015,67715,41515,34615,55816,18716,14416,24416,70416,57516,16415,90816,30016,76417,15217,59218,029
Stockholders' Equity12,63115,05315,11115,05215,03815,10915,23915,22715,20215,07715,17115,13515,12815,10415,15815,13515,150
Income Statement ($MM)2015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue1,1531,4911,5331,5461,6651,8421,4001,487
Cost of Revenue
Gross Profit
R&D
SG&A
Tax56-69104172535010344324722729412933
Net Income5496212102109207239120100-77244110134119217110150
Cash Flow ($MM)2015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating398397511308345441484397441597334315502427
Cash Investing-905-201-336-328-662-514-531-622-674-323-427-526-926-704
Cash Financing-116-220-182-1942241254217245-27576206558213